HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Future of Radiotherapy in Nasopharyngeal Carcinoma.

Abstract
Nasopharyngeal carcinoma (NPC) is a malignancy with unique clinical biological profiles such as associated Epstein-Barr virus infection and high radiosensitivity. Radiotherapy has long been recognized as the mainstay for the treatment of NPC. However, the further efficacy brought by radical radiotherapy has reached the bottleneck in advanced patients, who are prone to develop recurrence and distant metastasis after treatment. The application of photon therapy makes it possible for radiation dose escalation in refractory cases and may provide second chance for recurrent patients with less unrecoverable tissue damage. The concept of adaptive radiotherapy is put forward in consideration of target volume shrinkage during treatment. The replanning procedure offers better protection for the organ at risk. However, the best timing and candidates for adaptive radiotherapy is still under debate. The current tendency of artificial intelligence in NPC mainly focuses on image recognition, auto-segmentation and dose prediction. Although artificial intelligence is still in developmental stage, the future of it is promising.To further improve the efficacy of NPC, multimodality treatment is encouraged. In-depth studies on genetic and epigenetic variations help to explain the great heterogeneity among patients, and could further be applied to precise screening and prediction, personalized radiotherapy and the evolution of targeted drugs. Given the clinical benefit of immunotherapy in other cancers, the application of immunotherapy, especially immune checkpoint inhibitor, in NPC is also of great potential. Results from ongoing clinical trials combining immunotherapy with radiotherapy in NPC are expected.
AuthorsXue-Song Sun, Xiao-Yun Li, Qiu-Yan Chen, Lin-Quan Tang, Hai-Qiang Mai
JournalThe British journal of radiology (Br J Radiol) Vol. 92 Issue 1102 Pg. 20190209 (Oct 2019) ISSN: 1748-880X [Electronic] England
PMID31265322 (Publication Type: Journal Article)
Topics
  • Artificial Intelligence (trends)
  • Forecasting
  • Humans
  • Immunotherapy (methods)
  • Molecular Targeted Therapy (methods)
  • Nasopharyngeal Carcinoma (mortality, radiotherapy)
  • Nasopharyngeal Neoplasms (mortality, radiotherapy)
  • Organs at Risk (radiation effects)
  • Precision Medicine (methods)
  • Proton Therapy (methods)
  • Radiation Injuries (prevention & control)
  • Radiotherapy (methods)
  • Radiotherapy, Intensity-Modulated (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: